Clinical Trial Update: Nitric Oxide (NO) Activity and Diabetic Nephropathy [Phase 2, Phase 3]

View source ↗

Summary

Phase 2 and Phase 3 trials investigating nitric oxide activity in diabetic nephropathy have completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy

Drugs mentioned

• Nitric Oxide (nitric oxide)

Snippet

Sponsor: University of Erlangen-Nürnberg Medical School | Conditions: Diabetic Nephropathies | Phase 2, Phase 3 | Status: COMPLETED